Top Qs
Timeline
Chat
Perspective

Drozitumab

Monoclonal antibody From Wikipedia, the free encyclopedia

Remove ads

Drozitumab is a human monoclonal antibody in development for the treatment of cancers.[1][2] It targets Tumour Necrosis Factor Related Apoptosis-inducing Ligand (TRAIL), whose receptors are found on the surface of many types of malignant cells.[3][4] Drozitumab was developed by Genentech.

Quick Facts Monoclonal antibody, Type ...

Although drozitumab was studied in phase II trials for treating chondrosarcoma, colorectal cancer, non-Hodgkin lymphoma, and non-small cell lung cancer, development has been halted due to lack of clinical response.[3]

Remove ads

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads